[144] DARLING INGREDIENTS INC. SEC Filing
Darling Ingredients (DAR) filed a Form 144 reporting a proposed sale of 35,000 common shares. The sale is listed with an aggregate market value of $1,040,900 and an approximate sale date of 08/12/2025, to be executed through J.P. Morgan Securities LLC on the NYSE.
The filing shows the 35,000 shares were acquired through the issuer via stock options and performance stock units (PSUs) on dates between 03/18/2021 and 05/26/2022, with component lots of 19,198 PSUs and three option lots totaling 15,802 shares. The company has 158,158,847 shares outstanding as reported on the form.
- Proposed sale fully disclosed: 35,000 common shares and aggregate market value of $1,040,900 are reported
- Transaction origin transparently listed: shares came from stock options and PSUs with acquisition dates and lot sizes
- Broker and execution details provided: J.P. Morgan Securities LLC and NYSE execution noted
- None.
Insights
TL;DR: Routine insider sale notice; modest position size relative to outstanding shares.
The Form 144 discloses a proposed sale of 35,000 DAR common shares with an aggregate value of $1,040,900. The securities originate from vested compensation (stock options and PSUs) granted by the issuer between 2021 and 2022. The filing is a standard regulatory notice required before certain insider sales and does not by itself indicate a change in company fundamentals. Investors should note the sale is to be handled through J.P. Morgan on the NYSE and the filing reports 158,158,847 shares outstanding, providing context for the absolute size of the transaction.
TL;DR: Procedural disclosure of compensation-related share disposal; compliance with Rule 144 apparent.
The filing itemizes the lot-level origins of the 35,000 shares (PSUs and stock options) with acquisition dates and quantities, which supports transparency about the nature of the holdings being sold. The notice includes the required representation about material nonpublic information and specifies the broker and planned sale date. As presented, the document reads as a routine compliance filing rather than an indicator of governance or control changes.